**Core Concept**
The prognosis of Acute Lymphoblastic Leukemia (ALL) is influenced by various factors, including age at diagnosis, initial white blood cell count, and the presence of extramedullary involvement. In pediatric patients, age is a significant prognostic factor, with younger children generally having a poorer outcome.

**Why the Correct Answer is Right**
Children under the age of 2 years have a higher risk of relapse and lower overall survival rates compared to older children. This is attributed to several factors, including the presence of certain genetic abnormalities, such as MLL gene rearrangements, and the immaturity of the immune system, which can lead to a higher likelihood of infections and treatment-related complications. Furthermore, younger children with ALL often have a higher initial white blood cell count, which is also associated with a poorer prognosis.

**Why Each Wrong Option is Incorrect**
**Option B:** A total leukocyte count (TLC) of 4000-10,000 cells/μL is not a poor prognostic indicator in ALL. In fact, a high initial white blood cell count is generally associated with a poorer prognosis. However, this option is not as strongly prognostic as age at diagnosis.

**Option C:** Presence of testicular involvement at presentation is a poor prognostic indicator in ALL, but it is not the correct answer in this question. Testicular involvement is a form of extramedullary disease and is associated with a higher risk of relapse.

**Option D:** Presence of blasts in peripheral smear is a diagnostic criterion for ALL, but it is not a poor prognostic indicator in itself. The presence of blasts in the peripheral smear is a necessary finding for the diagnosis of ALL, but it does not provide information on the prognosis.

**Clinical Pearl / High-Yield Fact**
Children under the age of 2 years with ALL often require more intensive treatment regimens and have a higher risk of treatment-related complications, such as infections and secondary malignancies. Close monitoring and prompt intervention are essential to improve outcomes in this high-risk group.

✓ Correct Answer: A. Age < 2 year